Skip to main content
. 2021 May 27;16(5):e0252158. doi: 10.1371/journal.pone.0252158

Table 2. Associations between time in range 70–180 mg/dL and 28-day mortality using logistic regression models.

HbA1c <6.5% HbA1c ≥6.5%
Time in range Mortality / n Mortality rate Unadjusted OR Adjusted OR* Mortality / n Mortality rate Unadjusted OR Adjusted OR*
(95%CI) (95%CI) (95%CI) (95%CI)
Time in range (threshold at 80%)
<80% 124 / 394 32% 2.23 (1.65–3.01) 2.21 (1.60–3.05) 59 / 192 31% 0.78 (0.42–1.45) 0.64 (0.30–1.37)
≥80% 100 / 586 17% 1 (reference) 1 (reference) 21 / 58 36% 1 (reference) 1 (reference)
Time in range (10% incremental category)
<60% 78 / 205 38% 3.76 (2.53–5.58) 3.62 (2.36–5.53) 56 / 160 35% 1.77 (0.71–4.38) 1.19 (0.40–3.53)
60%-69% 24 / 86 28% 2.40 (1.39–4.16) 2.39 (1.33–4.28) 1 / 13 8% 0.27 (0.03–2.49) 0.13 (0.01–1.42)
70%-79% 22 / 103 21% 1.67 (0.96–2.88) 1.63 (0.92–2.91) 2 / 19 11% 0.39 (0.07–2.10) 0.14 (0.02–0.97)
80%-89% 43 / 178 24% 1.96 (1.26–3.06) 1.83 (1.14–2.93) 14 / 28 50% 3.29 (1.07–10.1) 1.81 (0.46–7.06)
≥90% 57 / 408 14% 1 (reference) 1 (reference) 7 / 30 23% 1 (reference) 1 (reference)
Time in range (10% decremental) 1.21 (1.14–1.29) 1.20 (1.12–1.28) 1.02 (0.94–1.12) 1.08 (0.96–1.21)
Time in range (quartile category)
Q1 (<53%) 60 / 156 39% 4.07 (2.55–6.48) 3.73 (2.26–6.14) 53 / 151 35% 1.71 (0.64–4.55) 1.21 (0.36–4.05)
Q2 (53%-80%) 70 / 260 27% 2.42 (1.57–3.74) 2.28 (1.44–3.61) 6 / 44 14% 0.50 (0.14–1.76) 0.17 (0.04–0.76)
Q3 (81%-93%) 55 / 268 21% 1.71 (1.09–2.67) 1.57 (0.98–2.53) 15 / 30 50% 3.17 (0.99–10.1) 2.06 (0.49–8.75)
Q4 (≥94%) 39 / 296 13% 1 (reference) 1 (reference) 6 / 25 24% 1 (reference) 1 (reference)

*Logistic regression adjusted for age, sex, Charlson comorbidity index, APACHE Ⅱ score, and primary diagnosis category (sepsis, cerebrovascular diseases, cardiac diseases, cardiac arrest, respiratory diseases, gastrointestinal diseases, trauma, postoperative, and others).

APACHE, Acute Physiology and Chronic Health Evaluation; HbA1c, glycosylated hemoglobin; OR, odds ratio; CI, confidence interval.